Coordination Funds

研究优先计划SPP2127旨在开发基于基因和细胞的疗法来治疗遗传性视网膜疾病。不仅在这两个领域的新方法将工作，但科学家也表征影响治疗结果的因素，并开发新的临床读出参数，随后在临床试验中使用。协调基金会旨在支持SPP内资助的不同团体之间的网络和合作。 一个主要目标是支持年轻科学家。这些目标将通过组织会议、暑期学校和实验室交流以及为两个新项目提供种子资金来实现。性别平等措施的资金可应要求提供，以支持女科学家。

The research priority program SPP2127 aims at developing gene and cell based therapies to treat inherited retinal diseases. Not only new approaches in both field will be worked at but scientist are also characterizing factors influencing the outcome of the therapy and develop new clinical readout parameter for subsequent use in clinical trials.The coordination fonds aims at supporting networking and cooperation between the different groups funded within the SPP. A major goal is to support young scientists. These goals will be accomplished by organizing meetings, summer schools and lab exchanges as well as by providing seed funding for two new projects. Funding for gender equality measures is available upon request to support female scientists.